Does ESCITALOPRAM OXALATE Cause Malignant neoplasm progression? 27 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Malignant neoplasm progression have been filed in association with ESCITALOPRAM OXALATE (Escitalopram). This represents 0.1% of all adverse event reports for ESCITALOPRAM OXALATE.
27
Reports of Malignant neoplasm progression with ESCITALOPRAM OXALATE
0.1%
of all ESCITALOPRAM OXALATE reports
0
Deaths
17
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ESCITALOPRAM OXALATE?
Of the 27 reports, 17 (63.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESCITALOPRAM OXALATE. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does ESCITALOPRAM OXALATE Cause?
Drug ineffective (2,792)
Anxiety (1,686)
Headache (1,643)
Somnolence (1,640)
Nausea (1,635)
Completed suicide (1,504)
Drug interaction (1,477)
Toxicity to various agents (1,446)
Fatigue (1,443)
Off label use (1,422)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ESCITALOPRAM OXALATE Alternatives Have Lower Malignant neoplasm progression Risk?
ESCITALOPRAM OXALATE vs ESKETAMINE
ESCITALOPRAM OXALATE vs ESLICARBAZEPINE
ESCITALOPRAM OXALATE vs ESMOLOL
ESCITALOPRAM OXALATE vs ESOMEPRAZOLE
ESCITALOPRAM OXALATE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE